These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31958164)

  • 1. Ultrasound Assessment of Disease Activity Prevents Disease-Modifying Antirheumatic Drug (DMARD) Escalation and May Reduce DMARD-Related Direct Costs in Rheumatoid Arthritis With Fibromyalgia: An Exploratory Study.
    Silva Chakr RMD; Santos JCO; Alves LDS; de Andrade NPB; Ranzolin A; Brenol CV
    J Ultrasound Med; 2020 Jul; 39(7):1271-1278. PubMed ID: 31958164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheumatoid arthritis with concomitant fibromyalgia: The role of ultrasound in assessing disease activity.
    Miladi S; Ben Ayed H; Fazaa A; Boussaa H; Makhlouf Y; Souabni L; Ouenniche K; Kassab S; Chekili S; Abdelghani KB; Laatar A
    Musculoskeletal Care; 2023 Dec; 21(4):1011-1019. PubMed ID: 37157133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheumatoid arthritis seems to have DMARD treatment decision influenced by fibromyalgia.
    Chakr RMDS; Brenol C; Ranzolin A; Bernardes A; Dalosto AP; Ferrari G; Scalco S; Olszewski V; Kohem C; Monticielo O; Brenol JCT; Xavier RM
    Rev Bras Reumatol Engl Ed; 2017; 57(5):403-411. PubMed ID: 29037312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is ultrasound a better target than clinical disease activity scores in rheumatoid arthritis with fibromyalgia? A case-control study.
    da Silva Chakr RM; Brenol JC; Behar M; Mendonça JA; Kohem CL; Monticielo OA; Brenol CV; Xavier RM
    PLoS One; 2015; 10(3):e0118620. PubMed ID: 25738587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tightening up? Impact of musculoskeletal ultrasound disease activity assessment on early rheumatoid arthritis patients treated using a treat to target strategy.
    Dale J; Purves D; McConnachie A; McInnes I; Porter D
    Arthritis Care Res (Hoboken); 2014 Jan; 66(1):19-26. PubMed ID: 24376248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclinical synovitis and tenosynovitis by ultrasonography (US) 7 score in patients with rheumatoid arthritis treated with synthetic drugs, in clinical remission by DAS28.
    Ventura-Ríos L; Sánchez Bringas G; Hernández-Díaz C; Cruz-Arenas E; Burgos-Vargas R
    Reumatol Clin (Engl Ed); 2019; 15(5):e5-e9. PubMed ID: 29198500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical synovitis measured by ultrasound in rheumatoid arthritis patients with clinical remission induced by synthetic and biological modifying disease drugs.
    Cruces M; Al Snih S; Serra-Bonett N; Rivas JC
    Reumatol Clin (Engl Ed); 2019; 15(4):218-222. PubMed ID: 29032909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of ultrasonography in assessing disease activity in patients with rheumatoid arthritis and associated fibromyalgia.
    Ghib LJ; Tămaş MM; Damian LO; Felea I; Muntean LM; Rednic N; Rednic S
    Med Ultrason; 2015 Sep; 17(3):339-44. PubMed ID: 26343083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenic cytokines can reflect the synovitis severity and treatment response to biologics in rheumatoid arthritis.
    Kim JW; Kong JS; Lee S; Yoo SA; Koh JH; Jin J; Kim WU
    Exp Mol Med; 2020 May; 52(5):843-853. PubMed ID: 32461558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a new erosion score by musculoskeletal ultrasound in patients with rheumatoid arthritis: is US ready for a new erosion score?
    Ohrndorf S; Messerschmidt J; Reiche BE; Burmester GR; Backhaus M
    Clin Rheumatol; 2014 Sep; 33(9):1255-62. PubMed ID: 24824913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synovitis and Tenosynovitis on Ultrasound as Predictors of DMARD Tapering Failure in Patients with Long-Standing Rheumatoid Arthritis in Clinical Remission or Low Disease Activity.
    Massignan Â; Mendonça da Silva Chakr R; Pamplona Bueno de Andrade N; Brenol CV
    J Ultrasound Med; 2021 Dec; 40(12):2549-2559. PubMed ID: 33492685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of Doppler ultrasound synovitis versus clinical synovitis with changes in native complement component levels in rheumatoid arthritis patients treated with biologic disease-modifying anti-rheumatic drugs.
    Montoro Alvarez M; Chong OY; Janta I; González C; López-Longo J; Monteagudo I; Valor L; Garrido J; Lau IS; Rosman A; Naredo E; Carreño L
    Clin Exp Rheumatol; 2015; 33(2):141-5. PubMed ID: 25665178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of the ultrasound examination of the hand and wrist joints in the management of established rheumatoid arthritis.
    Ceponis A; Onishi M; Bluestein HG; Kalunian K; Townsend J; Kavanaugh A
    Arthritis Care Res (Hoboken); 2014 Feb; 66(2):236-44. PubMed ID: 23983173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying markers of sustained remission in rheumatoid arthritis patients on long-term tapered biological disease-modifying antirheumatic drugs.
    Valor L; Garrido J; Martínez-Estupiñán L; Hernández-Flórez D; Janta I; López-Longo FJ; Monteagudo I; González CM; Naredo E
    Rheumatol Int; 2018 Aug; 38(8):1465-1470. PubMed ID: 29915991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting Disease Activity in Rheumatoid Arthritis With the Fibromyalgia Survey Questionnaire: Does the Severity of Fibromyalgia Symptoms Matter?
    Gorzewski AM; Heisler AC; Neogi T; Muhammad LN; Song J; Dunlop D; Bingham CO; Bolster MB; Clauw DJ; Marder W; Lee YC
    J Rheumatol; 2023 May; 50(5):684-689. PubMed ID: 36521924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial.
    Dale J; Stirling A; Zhang R; Purves D; Foley J; Sambrook M; Conaghan PG; van der Heijde D; McConnachie A; McInnes IB; Porter D
    Ann Rheum Dis; 2016 Jun; 75(6):1043-50. PubMed ID: 27026689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid Arthritis.
    Betts KA; Griffith J; Ganguli A; Li N; Douglas K; Wu EQ
    Clin Ther; 2016 May; 38(5):1205-16. PubMed ID: 27045991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound-detected bone erosion is a relapse risk factor after discontinuation of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis whose ultrasound power Doppler synovitis activity and clinical disease activity are well controlled.
    Kawashiri SY; Fujikawa K; Nishino A; Okada A; Aramaki T; Shimizu T; Umeda M; Fukui S; Suzuki T; Koga T; Iwamoto N; Ichinose K; Tamai M; Mizokami A; Nakamura H; Origuchi T; Ueki Y; Aoyagi K; Maeda T; Kawakami A
    Arthritis Res Ther; 2017 May; 19(1):108. PubMed ID: 28545509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
    Ciubotariu E; Gabay C; Finckh A;
    J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DAS28 in rheumatoid arthritis and fibromyalgia patients.
    Leeb BF; Andel I; Sautner J; Nothnagl T; Rintelen B
    Rheumatology (Oxford); 2004 Dec; 43(12):1504-7. PubMed ID: 15252215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.